Get the Daily Brief
Latest Biotech News
AI Models Unveil Key Gene Combinations Driving Complex Diseases
Northwestern University biophysicists developed a generative AI model, TWAVE, to decipher gene sets underlying polygenic diseases like diabetes and cancer. By integrating limited gene expression...
Tufts Chemists Advance Next-Gen Multireceptor Weight Loss Drugs
Researchers at Tufts University have designed a novel drug candidate targeting four hormone receptors—including GLP-1, GIP, and glucagon—to improve efficacy and safety in obesity management. This...
Argenx Expands Autoimmune Drug Vyvgart Trials With Promising Results
Argenx announced encouraging preliminary data for its antibody drug Vyvgart in two additional autoimmune diseases beyond its approved indications. The company is testing Vyvgart in multiple...
Recursion Pharmaceuticals Lays Off 20% As Biotech Funding Pressures Mount
Recursion Pharmaceuticals is cutting approximately 20% of its workforce in response to pipeline pruning and challenging capital markets. After merging with AI drug discovery firm Exscientia,...
FDA Approves Merck’s Pediatric RSV Antibody Amid CDC Panel Shakeup
The FDA has approved Merck's Enflonsia (clesrovimab), a monoclonal antibody for preventing respiratory syncytial virus (RSV) lower respiratory tract disease in infants under 12 months. This...
Recursion Cuts 20% Workforce Amid Funding Pressures
Recursion Pharmaceuticals announced a workforce reduction of approximately 20%, citing capital market challenges and pipeline restructuring. The layoffs signal financial pressures and strategic...
Insilico’s Nach01 Model Debuts on AWS for Drug Design
Insilico Medicine launched the Nach01 foundation AI model on AWS Marketplace, integrating multimodal data processing to enhance accuracy and scalability in molecular prediction and retrosynthesis,...
NIH Staff Rally Against Politicization and Grant Cuts
Over 300 NIH staff members have publicly protested drastic funding reductions and grant terminations under the current administration, highlighting risks to biomedical research integrity and...
Innovations in Sustainable and Precision Agriculture and Environmental Science
Multidisciplinary teams have developed new techniques for agriculture and environmental sustainability: the Rice Blast Index (RBI) employs UAV hyperspectral imaging for early fungal disease...
Regulatory Turmoil at CDC and Vaccine Advisory Panels
Health and Human Services Secretary Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices (ACIP), prompting concerns over vaccine policy direction...
Breakthrough Diagnostics and Therapeutics for Neurological and Metabolic Diseases
IU School of Medicine received FDA clearance for a blood test detecting amyloid plaques in Alzheimer’s disease through phosphorylated tau biomarkers. A novel artificial pancreas technology using...
Biotech Industry Investment and Market Movements
The biotech and med-tech sectors witnessed significant financing activities with Med-tech firms raising billions through numerous deals in May 2025. Antares Therapeutics secured $177 million in...
Innovations in Cancer Therapy and Modeling
Nagoya University researchers engineered next-generation CAR-T cells targeting Eva1 protein to enhance solid tumor immunotherapy. CIC bioGUNE elucidated molecular drivers of aggressive metastatic...
AI and Computational Tools Accelerate Drug Discovery and Gene Research
Insilico Medicine introduced Nach01, a multimodal foundation AI model on AWS Marketplace designed to enhance generative chemistry capabilities in drug discovery. Separately, Northwestern...
Recursion Lays Off 20% Staff Following Pipeline Streamlining
Recursion Pharmaceuticals disclosed a workforce reduction of approximately 20%—about 160 jobs—citing pipeline pruning and challenges in biotech capital markets. The restructuring aims to optimize...
Merck Advances in Cholesterol and RSV Markets Amidst Regulatory Shifts
Merck achieved positive outcomes from two Phase III trials of its oral PCSK9 inhibitor enlicitide decanoate, demonstrating significant LDL cholesterol reductions in hyperlipidemia patients....
NIH Funding Crisis Deepens Amid Staff Protests
More than 300 current and former NIH staff have signed the Bethesda Declaration protesting severe funding cuts and workforce reductions at the National Institutes of Health. Highlighting the...
FDA Halts Gilead's HIV Combo Therapy Trials Amid Safety Concerns
FDA imposed a clinical hold on Gilead Sciences’ multiple trials involving its experimental long-acting HIV combination pills after participants exhibited declines in immune cell counts, raising...
Innovative CAR-T Cells Target Eva1 to Combat Solid Tumors Effectively
Researchers developed a next-generation CAR-T therapy targeting the Eva1 antigen, overcoming historic barriers in treating solid tumors. By engineering enhanced receptor components, the therapy...
Merck’s Oral PCSK9 Inhibitor Cuts LDL in Pivotal Phase III Trials
Merck & Co. announced positive results from two Phase III trials of its oral PCSK9 inhibitor, enlicitide decanoate, showing statistically significant and clinically meaningful reductions in LDL...